Results 91 to 100 of about 30,704 (265)
Applied SciencesBackground: The pharmaceutical industry is faced with the problem of how to design and conduct tests to assess photostability during drug use and storage.
Michał Meisner, Beata Sarecka-Hujar
doaj +1 more source
Scalable Room‐Temperature Terahertz Graphene Cameras
Small Methods, EarlyView.ABSTRACT Terahertz (THz) imaging has emerged as a powerful tool for non‐destructive, label‐free analysis across several scientific disciplines, ranging from materials science to biomedical research. By capturing the spatial‐dependent information in a broad range of frequencies, this technique enables the identification of chemical composition ...
Lili Shi +2 more
wiley +1 more source
Safety Science and Technology, EarlyView.Tannic acid‐derived Schiff base (TBFe) designed with catalytic carbonization performance creates multifunctional flame‐retardant intumescent PLA with superior anti‐dripping performance, enhancement in strength, good spinnability and UV resistance reaches > 99.9% in UVA/UVB ranges.
Xu Jin +6 more
wiley +1 more source
Recovery of Pure PVC From Pharmaceutical Composite Packaging via Dissolution‐Based Recycling
Journal of Vinyl and Additive Technology, EarlyView.Closed‐loop pathway for pharmaceutical blister waste via selective dissolution‐based recycling (DBR) enables separation of PVDC and aluminum, PVC recovery and reprocessing into films with 30 phr recycled content, and validation for thermoforming applications.
Martin Schlummer +5 more
wiley +1 more source
Simulation research on the blister evolution behaviors of UMo/Zr monolithic fuel elements
Frontiers in Energy ResearchBlister behavior is one of the main failure modes of UMo/Zr monolithic fuel elements during irradiation. The temperature of fuel elements may increase greatly so that the fuel elements may be destroyed.
Tang Changbing +5 more
doaj +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe +4 more
wiley +1 more source
LC‐OCT of Dermatitis Herpetiformis
JEADV Clinical Practice, EarlyView.
Daniele Omar Traini, Gerardo Palmisano
wiley +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Biologic therapies targeting Type 2 inflammation are increasingly used in bullous pemphigoid, yet the relationship between pruritus and distinct disease domains remains incompletely defined. We conducted a retrospective international dual‐center study of 25 patients with bullous pemphigoid treated with dupilumab, omalizumab, or tralokinumab ...
Ruggero Cascio Ingurgio +6 more
wiley +1 more source